Trial Outcomes & Findings for Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344) (NCT NCT00711087)

NCT ID: NCT00711087

Last Updated: 2021-01-06

Results Overview

This outcome measure was not able to be determined due to the subject being lost to follow-up. The subject no longer returns phone calls or visits the clinic.

Recruitment status

TERMINATED

Study phase

PHASE2

Target enrollment

1 participants

Primary outcome timeframe

2.5 years

Results posted on

2021-01-06

Participant Flow

Participant milestones

Participant milestones
Measure
ARM 2
Patients in ARM 2 randomized to receive placebo (saline) injections on Days 0 and 90.
ARM 1
Patients in ARM 1 randomized to receive 100 units of BOTOX-A on Day 0 and Day 90
Overall Study
STARTED
1
0
Overall Study
COMPLETED
0
0
Overall Study
NOT COMPLETED
1
0

Reasons for withdrawal

Reasons for withdrawal
Measure
ARM 2
Patients in ARM 2 randomized to receive placebo (saline) injections on Days 0 and 90.
ARM 1
Patients in ARM 1 randomized to receive 100 units of BOTOX-A on Day 0 and Day 90
Overall Study
Lost to Follow-up
1
0

Baseline Characteristics

Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
ARM 1
Subjects randomized to this group will receive placebo.
ARM 2
n=1 Participants
Subjects randomized to receive 100 units of BOTOX-A injections on Days 0 and 90.
Total
n=1 Participants
Total of all reporting groups
Age, Continuous
1 years
n=7 Participants
1 years
n=5 Participants
Sex: Female, Male
Female
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
1 participants
n=7 Participants
1 participants
n=5 Participants

PRIMARY outcome

Timeframe: 2.5 years

Population: Early spinal cord injury

This outcome measure was not able to be determined due to the subject being lost to follow-up. The subject no longer returns phone calls or visits the clinic.

Outcome measures

Outcome data not reported

Adverse Events

ARM 2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

ARM 1

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Christopher P. Smith, MD, MBA, MSS

Baylor College of Medicine

Phone: 713-798-7498

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place